Research Article
MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
Table 2
Average
value of overexpressed microRNAs in malignant pleural mesothelioma compared with benign asbestos-related pleural effusion.
| ā | MPM | BAPE | Fold change | value* |
| hsa-miR-484 | 7.06 | 9.54 | 5.58 | 0.010 | hsa-miR-320 | 6.62 | 8.14 | 2.87 | 0.017 | hsa-let-7a | 8.85 | 12.65 | 13.93 | 0.019 | hsa-miR-744 | 11.67 | 13.76 | 4.26 | 0.019 | hsa-miR-20a | 10.65 | 13.16 | 5.7 | 0.019 | hsa-miR-193b | 8.09 | 9.69 | 3.03 | 0.019 | hsa-let-7d | 10.18 | 12.72 | 5.82 | 0.045 | hsa-miR-125a-5p | 8.8 | 11.83 | 8.17 | 0.045 | hsa-miR-92a | 9.93 | 11.19 | 2.39 | 0.045 | has-miR-155 | 8.77 | 10.43 | 3.16 | 0.045 | hsa-miR-152 | 11.93 | 13.48 | 2.93 | 0.047 |
|
|
[26]. MPM: malignant pleural mesothelioma; BAPE: benign asbestos-related pleural effusion.
|